Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| CORZ | Duchene Todd M | See remarks | 26.10.2026 | Verkauf | 13,80 | 5.500 | 75.900 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 26.10.2026 | Verkauf | 13,27 | 4.500 | 59.694 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 19.10.2026 | Verkauf | 13,87 | 10.000 | 138.744 | Form 4 |
| CORZ | Sullivan Adam Taylor | Chief Executive Officer | 16.10.2026 | Steuer-Abgabe | 14,46 | 21.839 | 315.683 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 16.10.2026 | Steuer-Abgabe | 14,46 | 6.382 | 92.252 | Form 4 |
| CORT | Wilson James N | Director | 15.10.2026 | Verkauf | 116,30 | 300 | 34.889 | Form 4 |
| CORT | Wilson James N | Director | 15.10.2026 | Verkauf | 115,39 | 3.046 | 351.476 | Form 4 |
| CORT | Wilson James N | Director | 15.10.2026 | Verkauf | 114,48 | 6.654 | 761.717 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 12.10.2026 | Verkauf | 15,12 | 10.000 | 151.160 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 05.10.2026 | Verkauf | 16,31 | 10.000 | 163.056 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 02.10.2026 | Verkauf | 116,59 | 5.147 | 600.063 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 02.10.2026 | Verkauf | 115,73 | 2.086 | 241.412 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 02.10.2026 | Verkauf | 114,52 | 1.100 | 125.973 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 02.10.2026 | Optionsausübung | 21,63 | 8.333 | 180.243 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 02.10.2026 | Verkauf | 116,54 | 4.744 | 552.869 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 02.10.2026 | Verkauf | 115,70 | 4.446 | 514.389 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 02.10.2026 | Optionsausübung | 19,26 | 5.833 | 112.344 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 02.10.2026 | Optionsausübung | 13,56 | 3.357 | 45.521 | Form 4 |
| CORT | Maduck Sean | See Remarks | 02.10.2026 | Verkauf | 116,55 | 8.744 | 1.019.143 | Form 4 |
| CORT | Maduck Sean | See Remarks | 02.10.2026 | Verkauf | 116,12 | 15.843 | 1.839.741 | Form 4 |
| CORT | Maduck Sean | See Remarks | 02.10.2026 | Optionsausübung | 8,27 | 24.587 | 203.334 | Form 4 |
| CORZ | Sullivan Adam Taylor | Chief Executive Officer | 01.10.2026 | Steuer-Abgabe | 15,98 | 23.508 | 375.658 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 01.10.2026 | Steuer-Abgabe | 15,98 | 8.228 | 131.483 | Form 4 |
| COR | Krikorian Lazarus | SVP & Chief Accounting Officer | 01.10.2026 | Verkauf | 303,18 | 986 | 298.935 | Form 4 |
| COR | Sanchez Robert E | Director | 01.10.2026 | Zuteilung | — | 275 | — | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 01.10.2026 | Verkauf | 115,40 | 810 | 93.473 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 01.10.2026 | Optionsausübung | 13,56 | 810 | 10.984 | Form 4 |
| CORT | Maduck Sean | See Remarks | 01.10.2026 | Verkauf | 115,54 | 413 | 47.717 | Form 4 |
| CORT | Maduck Sean | See Remarks | 01.10.2026 | Optionsausübung | 8,27 | 413 | 3.416 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 28.09.2026 | Verkauf | 16,76 | 10.000 | 167.586 | Form 4 |
| CORT | Robb Gary Charles | Chief Business Officer | 24.09.2026 | Schenkung | — | 5.000 | — | Form 4 |
| CORT | Robb Gary Charles | Chief Business Officer | 24.09.2026 | Schenkung | — | 17.100 | — | Form 4 |
| CORZ | Duchene Todd M | See remarks | 21.09.2026 | Verkauf | 18,37 | 10.000 | 183.746 | Form 4 |
| CORT | Robb Gary Charles | Chief Business Officer | 17.09.2026 | Optionsausübung | 8,27 | 17.493 | 144.667 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 16.09.2026 | Verkauf | 100,82 | 296 | 29.843 | Form 4 |
| COR | Greenberg Lon R | Director | 16.09.2026 | Verkauf | 321,30 | 1.280 | 411.264 | Form 4 |
| CORZ | Weiss Eric Stanton | Director | 15.09.2026 | Kauf | 16,33 | 6.000 | 97.980 | Form 4 |
| CORT | Wilson James N | Director | 15.09.2026 | Verkauf | 111,70 | 2.800 | 312.771 | Form 4 |
| CORT | Wilson James N | Director | 15.09.2026 | Verkauf | 110,84 | 400 | 44.335 | Form 4 |
| CORT | Wilson James N | Director | 15.09.2026 | Verkauf | 110,27 | 6.800 | 749.835 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 14.09.2026 | Verkauf | 17,14 | 10.000 | 171.362 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 14.09.2026 | Verkauf | 114,12 | 2.188 | 249.686 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 14.09.2026 | Verkauf | 113,32 | 7.812 | 885.261 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 14.09.2026 | Optionsausübung | 13,56 | 7.404 | 100.398 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 14.09.2026 | Optionsausübung | 11,35 | 2.596 | 29.465 | Form 4 |
| CORZ | Duchene Todd M | See remarks | 08.09.2026 | Verkauf | 18,67 | 10.000 | 186.735 | Form 4 |
| CORT | Maduck Sean | See Remarks | 02.09.2026 | Steuer-Abgabe | 113,38 | 117 | 13.265 | Form 4 |
| CORT | Mokari Atabak | Chief Financial Officer | 02.09.2026 | Steuer-Abgabe | 113,38 | 102 | 11.565 | Form 4 |
| CORT | Robb Gary Charles | Chief Business Officer | 02.09.2026 | Steuer-Abgabe | 113,38 | 91 | 10.318 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 02.09.2026 | Verkauf | 115,44 | 1.225 | 141.413 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 02.09.2026 | Verkauf | 114,58 | 5.621 | 644.042 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 02.09.2026 | Verkauf | 113,72 | 1.606 | 182.632 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 02.09.2026 | Verkauf | 112,40 | 974 | 109.474 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 02.09.2026 | Verkauf | 111,37 | 1.537 | 171.181 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 02.09.2026 | Verkauf | 110,70 | 23.770 | 2.631.349 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 02.09.2026 | Verkauf | 109,35 | 23.600 | 2.580.674 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 02.09.2026 | Optionsausübung | 21,63 | 58.333 | 1.261.743 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 02.09.2026 | Steuer-Abgabe | 113,38 | 102 | 11.565 | Form 4 |
| CORT | Lyon Joseph Douglas | See Remarks | 02.09.2026 | Steuer-Abgabe | 113,38 | 72 | 8.163 | Form 4 |
| CORT | Guyer William | Chief Development Officer | 01.09.2026 | Zuteilung | — | 164 | — | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).